Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
PTLA | PORTOLA PHARMACEUTICALS INC | Garland J. Scott | President and CEO | Jun 18, 2020 | Option Exercise | $8.36 | 1,173 | 9,806 | 1,173 | Jul 02, 2020, 04:28 PM | |
PTLA | PORTOLA PHARMACEUTICALS INC | Garland J. Scott | President and CEO | Jul 02, 2020 | Option Exercise | $18.00 | 25,702 | 462,636 | 0 | Jul 02, 2020, 04:28 PM | |
PTLA | PORTOLA PHARMACEUTICALS INC | Garland J. Scott | President and CEO | Feb 03, 2020 | Option Exercise | $12.89 | 5,623 | 72,480 | 177,928 | Feb 04, 2020, 06:54 PM | |
PTLA | PORTOLA PHARMACEUTICALS INC | Garland J. Scott | President and CEO | Nov 01, 2019 | Option Exercise | $29.84 | 21,549 | 643,022 | 133,551 | Nov 04, 2019, 07:28 PM | |
RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commercial Officer | Sep 01, 2016 | Option Exercise | $32.00 | 18,512 | 592,384 | 16,042 | Sep 02, 2016, 12:27 PM | |
RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commercial Officer | Aug 15, 2016 | Option Exercise | $31.89 | 705 | 22,482 | 14,345 | Aug 17, 2016, 04:24 PM | |
RLYP | Relypsa Inc | Garland J. Scott | SVP & Chief Commercial Officer | Jun 03, 2016 | Option Exercise | $19.96 | 783 | 15,629 | 15,050 | Jun 07, 2016, 06:50 PM |